Reply to: "Probability of HBsAg loss after nucleos(t)ide analogue withdrawal depends on HBV genotype and viral antigen levels"

Milan J. Sonneveld*, Shao Ming Chiu, Chien Hung Chen, Benjamin Maasoumy, the CREATE study group

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)1224-1226
Number of pages3
JournalJournal of Hepatology
Volume77
Issue number4
DOIs
Publication statusPublished - 1 Oct 2022

Bibliographical note

Funding Information:
The CREATE study was supported by Fujirebio. Materials for HBcrAg testing were provided free of charge to several participating centers.The authors would like to thank Laura Vernoux (Fujirebio) for supporting the CREATE project.

Cite this